BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70 AND Treatment
10270 results:

  • 1. Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    Broshkevitch CJ; Barnabas RV; Liu G; Palanee-Phillips T; Rao DW
    PLoS One; 2024; 19(5):e0301997. PubMed ID: 38781268
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis.
    Liu X; Xie X; Li Q; Xie X; Xiong M; Han W; Xie W
    FASEB J; 2024 May; 38(10):e23685. PubMed ID: 38780518
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
    Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
    Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
    Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
    BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
    Dong B; Zhou SF
    BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
    BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
    Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
    Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
    PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metformin for endometrial hyperplasia.
    Shiwani H; Clement NS; Daniels JP; Atiomo W
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
    Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epidemiology of uterine cancer in Sarawak, Borneo, A 20-Year Review.
    Jawa D; Wong KY; Wahab MB; Azhar A; Foong EJ; Joseph EM; Pangkas J; Ooi CH
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1143-1153. PubMed ID: 38679973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Wang D; Fang X
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():202-208. PubMed ID: 38678796
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
    Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
    Friedman CF; Manning-Geist BL; Zhou Q; Soumerai T; Holland A; Da Cruz Paula A; Green H; Ozsoy MA; Iasonos A; Hollmann T; Leitao MM; Mueller JJ; Makker V; Tew WP; O'Cearbhaill RE; Liu YL; Rubinstein MM; Troso-Sandoval T; Lichtman SM; Schram A; Kyi C; Grisham RN; Causa Andrieu P; Wherry EJ; Aghajanian C; Weigelt B; Hensley ML; Zamarin D
    Nat Med; 2024 May; 30(5):1330-1338. PubMed ID: 38653864
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 514.